OTCMKTS:KNWN Know Labs Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Know Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $2.24 -0.26 (-10.41%) (As of 07/5/2022 12:00 AM ET) Add Compare Share Today's Range$2.16▼$2.5850-Day Range$1.40▼$2.5052-Week Range$1.15▼$3.94Volume26,254 shsAverage Volume60,795 shsMarket Capitalization$98.00 millionP/E RatioN/ADividend YieldN/APrice Target$7.00 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesHeadlinesSEC FilingsShort Interest Know Labs MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside212.8% Upside$7.00 Price TargetShort InterestHealthy0.73% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.1.55 out of 5 stars 3.5 Analyst's Opinion Consensus RatingKnow Labs has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $7.00, Know Labs has a forecasted upside of 212.8% from its current price of $2.24.Amount of Analyst CoverageKnow Labs has received no research coverage in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted0.73% of the outstanding shares of Know Labs have been sold short.Short Interest Ratio / Days to CoverKnow Labs has a short interest ratio ("days to cover") of 4.1.Change versus previous monthShort interest in Know Labs has recently decreased by 5.04%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldKnow Labs does not currently pay a dividend.Dividend GrowthKnow Labs does not have a long track record of dividend growth. Previous Next 0.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for KNWN. Previous Next 1.7 News and Social Media Coverage News SentimentKnow Labs has a news sentiment score of 0.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.53 average news sentiment score of Business Services companies.Search Interest2 people have searched for KNWN on MarketBeat in the last 30 days. MarketBeat FollowsOnly 4 people have added Know Labs to their MarketBeat watchlist in the last 30 days. This is a decrease of -20% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Know Labs insiders have not sold or bought any company stock.Percentage Held by Insiders44.00% of the stock of Know Labs is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 10.59% of the stock of Know Labs is held by institutions. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Know Labs are expected to remain at ($0.08) per share in the coming year.Price to Earnings Ratio vs. the MarketThe P/E ratio of Know Labs is -2.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Know Labs is -2.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioKnow Labs has a P/B Ratio of 55.94. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive KNWN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Know Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address About Know Labs (OTCMKTS:KNWN) StockKnow Labs, Inc. focuses on the development and commercialization of proprietary technologies in the United States. Its technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The company refers to its technology as Bio-RFID. The Bio-RFID technology can be integrated into various wearable, mobile, or bench-top form factors. Its first application of Bio-RFID technology is a product marketed as a glucose monitor that provide the user with real time information on their blood glucose levels. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is headquartered in Seattle, Washington.Read More KNWN Stock News HeadlinesJune 14, 2022 | americanbankingnews.comComparing Know Labs (KNWN) and Its PeersJune 13, 2022 | americanbankingnews.comKnow Labs (KNWN) versus The Competition Critical AnalysisJune 12, 2022 | americanbankingnews.comHead-To-Head Analysis: Know Labs (KNWN) vs. The CompetitionJune 12, 2022 | americanbankingnews.comReviewing Know Labs (KNWN) & Its RivalsMay 27, 2022 | msn.comHere’s What Scientists Know About Paxlovid ReboundMay 26, 2022 | msn.comScientists grow cells on a robot skeleton (but don’t know what to do with them yet)May 25, 2022 | msn.comMonkeypox vaccines are available for some people. Here’s what you need to know.May 24, 2022 | finance.yahoo.comKnow Labs Expands Leadership Team, Adds Chief Financial Officer and Chief Product Officer, As It Gets Closer to FDA Clearance ApplicationMay 24, 2022 | ca.finance.yahoo.comAbner Labs Appoints Skins Agency as Strategic Partner for UI/UX ExperienceMay 20, 2022 | msn.comNew LMPD, DNA lab partnership credited with helping make arrest in murder of Louisville motherMay 11, 2022 | bizjournals.comFive things you need to know today, and corporate activism meets abortionMay 11, 2022 | cnet.comBig Early Season Wildfires Tearing Through the Southwest: What You Need to KnowMay 10, 2022 | forbes.comTwo Creators Share What It Was Like Participating In The Disney Creators LabMay 10, 2022 | finance.yahoo.comKnow Labs, Inc. Discusses Significance of Patented Non-Invasive Blood Glucose Monitoring Technology with The Stock Day PodcastMay 9, 2022 | nz.finance.yahoo.comZai Lab (NASDAQ:ZLAB) dips 29% this week as increasing losses might not be inspiring confidence among its investorsMay 9, 2022 | nypost.comCongress must investigate news taxpayer-funded EcoHealth covered up yet more in Wuhan labMay 6, 2022 | msn.comFirst confirmed case in Texas of bird flu found. Here’s what you need to know.May 4, 2022 | msn.comLab-Grown Brain Experiment Reverses The Effects of Autism-Linked GeneMay 4, 2022 | markets.businessinsider.comUnchained Labs revs up its gene therapy engine, acquires NanoView Biosciences!May 4, 2022 | foxnews.comBill Gates claims 'it's quite clear' coronavirus originated in bats, dismisses lab leak theoryMay 4, 2022 | bizjournals.comRespira Labs is developing a device that could help patients with lung ailments. Inno Madness brought it international attention.April 29, 2022 | msn.comPit bulls are aggressive, while Labs are friendly? Your dog's breed actually has little to do with its behavior, study findsApril 27, 2022 | msn.comRocket Lab catches dummy booster with a helicopter in dramatic new videoApril 26, 2022 | apnews.comRapid Dose Therapeutics and Skycare Compounding Labs to Provide Patients with a Novel Oral Delivery Option for Pharmaceutical ProductsApril 25, 2022 | msn.comMom Dragged for Sharing Adult Offspring's Blood Work Labs on Her FacebookSee More Headlines Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry Measuring & controlling devices, not elsewhere classified Sub-IndustryN/A SectorBusiness Services Current SymbolOTCMKTS:KNWN CUSIPN/A CIK1074828 Webwww.knowlabs.co Phone(206) 903-1351Fax206-826-0451Employees12Year FoundedN/ACompany Calendar Last Earnings8/07/2019Today7/06/2022Fiscal Year End9/30/2022Price Target and Rating Average Stock Price Forecast$7.00 High Stock Price Forecast$7.00 Low Stock Price Forecast$7.00 Forecasted Upside/Downside+212.8%Consensus RatingBuy Rating Score (0-4)3 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.76) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-25,360,000.00 Net MarginsN/A Pretax Margin-600.57% Return on Equity-968.13% Return on Assets-192.31% Debt Debt-to-Equity Ratio0.06 Current Ratio2.11 Quick Ratio2.11 Sales & Book Value Annual Sales$120,000.00 Price / Sales816.69 Cash FlowN/A Price / Cash FlowN/A Book Value$0.04 per share Price / Book55.94Miscellaneous Outstanding Shares43,800,000Free Float24,529,000Market Cap$98.00 million OptionableNot Optionable Beta2.56 Know Labs Frequently Asked Questions Should I buy or sell Know Labs stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Know Labs in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Know Labs stock. View analyst ratings for Know Labs or view top-rated stocks. What is Know Labs' stock price forecast for 2022? 1 analysts have issued twelve-month price targets for Know Labs' shares. Their KNWN stock forecasts range from $7.00 to $7.00. On average, they anticipate Know Labs' stock price to reach $7.00 in the next year. This suggests a possible upside of 212.8% from the stock's current price. View analysts' price targets for Know Labs or view top-rated stocks among Wall Street analysts. How has Know Labs' stock performed in 2022? Know Labs' stock was trading at $1.6975 at the start of the year. Since then, KNWN shares have increased by 31.8% and is now trading at $2.2375. View the best growth stocks for 2022 here. How were Know Labs' earnings last quarter? Know Labs, Inc. (OTCMKTS:KNWN) issued its quarterly earnings data on Wednesday, August, 7th. The company reported ($0.04) earnings per share (EPS) for the quarter. The business earned $0.38 million during the quarter. View Know Labs' earnings history. Who are Know Labs' key executives? Know Labs' management team includes the following people: Mr. Ronald P. Erickson J.D., Founder, Chairman & Treasurer (Age 78, Pay $366.04k)Mr. Phillip A. Bosua, CEO & Director (Age 48, Pay $663.76k)Mr. Peter Joseph Conley, CFO & Sr. VP of Intellectual PropertyMr. Leo Trautwein, Chief Marketing OfficerDr. James H. Anderson Jr., M.D., Chief Medical Officer and Chairman of Medical, Scientific & Regulatory Advisory BoardMr. Steven T. Kent, Chief Product OfficerMr. Masanori Takee, Sr. VP of Software Engineering Who are some of Know Labs' key competitors? Some companies that are related to Know Labs include Quantum-Si (QSI), Owlet (OWLT), Mechanical Technology (MKTY), Geospace Technologies (GEOS), Sierra Monitor (SRMC), Midwest Energy Emissions (MEEC), Autoscope Technologies (AATC), Callitas Health (MPHMF), Mikros Systems (MKRS) and Oxford Instruments (OXINF). View all of KNWN's competitors. What other stocks do shareholders of Know Labs own? Based on aggregate information from My MarketBeat watchlists, some companies that other Know Labs investors own include Denali Therapeutics (DNLI), Co-Diagnostics (CODX), Onconova Therapeutics (ONTX), Sierra Oncology (SRRA), Acura Pharmaceuticals (ACUR), Actinium Pharmaceuticals (ATNM), AzurRx BioPharma (AZRX), CytoDyn (CYDY), (GBSN) (GBSN) and Home Depot (HD). What is Know Labs' stock symbol? Know Labs trades on the OTCMKTS under the ticker symbol "KNWN." How do I buy shares of Know Labs? Shares of KNWN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Know Labs' stock price today? One share of KNWN stock can currently be purchased for approximately $2.24. How much money does Know Labs make? Know Labs (OTCMKTS:KNWN) has a market capitalization of $98.00 million and generates $120,000.00 in revenue each year. The company earns $-25,360,000.00 in net income (profit) each year or ($0.76) on an earnings per share basis. How many employees does Know Labs have? Know Labs employs 12 workers across the globe. How can I contact Know Labs? Know Labs' mailing address is 500 UNION STREET SUITE 810, SEATTLE WA, 98101. The official website for Know Labs is www.knowlabs.co. The company can be reached via phone at (206) 903-1351, via email at vsul@liolios.com, or via fax at 206-826-0451. This page (OTCMKTS:KNWN) was last updated on 7/6/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
